Although leukemia therapy mainly consists of nonselective chemotherapy, optionally followed by BM transplantation,7 multiple approved therapies targeting recurrently mutated epigenetic proteins with DNA demethylation agents, or IDH inhibitors have been reported as effective treatment strategies for leukemia.6 This evidence concerns the gene IDH1 and leukemia.